sulfasalazine has been researched along with DRESS Syndrome in 28 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"Drug hypersensitivity syndrome (DHS) induced by sulfasalazine is a serious systemic delayed adverse drug reaction, which is associated with significant morbidity and mortality." | 8.12 | Drug hypersensitivity syndrome induced by sulfasalazine: A case report. ( Chen, DH; Guan, CL; Shen, GY; Xu, C; Zhang, YG; Zhou, HR, 2022) |
"DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe, rare and potentially lethal idiosyncratic condition associated with the use of some drugs." | 5.56 | [DRESS syndrome induced by sulfasalazine. Report of one case]. ( Arce, E; Blamey, R; Flores, L; Quera, R, 2020) |
"Both DRESS and agranulocytosis were not reported previously with SSZ." | 5.42 | Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor. ( Ben Salem, C; Fathallah, N; Hachfi, W; Letaief, A; Rached, S; Slim, R, 2015) |
"The most commonly reported drugs are allopurinol, sulfasalazine and minocycline, which pose a very high risk for DRESS syndrome development, followed by strontium ranelate and dapsone." | 4.95 | Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist. ( Adwan, MH, 2017) |
"Drug hypersensitivity syndrome (DHS) induced by sulfasalazine is a serious systemic delayed adverse drug reaction, which is associated with significant morbidity and mortality." | 4.12 | Drug hypersensitivity syndrome induced by sulfasalazine: A case report. ( Chen, DH; Guan, CL; Shen, GY; Xu, C; Zhang, YG; Zhou, HR, 2022) |
"Diagnosing drug reaction with eosinophilia and systemic symptoms (DRESS) is challenging." | 1.56 | Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study. ( Barbaud, A; Bernier, C; Milpied, B; Puymirat, E; Soria, A; Veyrac, G, 2020) |
"DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe, rare and potentially lethal idiosyncratic condition associated with the use of some drugs." | 1.56 | [DRESS syndrome induced by sulfasalazine. Report of one case]. ( Arce, E; Blamey, R; Flores, L; Quera, R, 2020) |
"The histopathology of DRESS syndrome highlights various associated inflammatory patterns in a single biopsy." | 1.42 | Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. ( Bastuji-Garin, S; Chosidow, O; de Feraudy, S; Delfau-Larue, MH; Duong, TA; Ortonne, N; Roujeau, JC; Valeyrie-Allanore, L; Wechsler, J; Wolkenstein, P, 2015) |
"Both DRESS and agranulocytosis were not reported previously with SSZ." | 1.42 | Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor. ( Ben Salem, C; Fathallah, N; Hachfi, W; Letaief, A; Rached, S; Slim, R, 2015) |
"We herein report a case of DRESS syndrome who presented with fever and rash, secondary to sulfasalazine ingestion." | 1.42 | DRESS Syndrome: Drug Rash with Eosinophilia and Systemic Symptoms. ( Shah, M; Thacker, H; Tulle, R, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 18 (64.29) | 24.3611 |
2020's | 10 (35.71) | 2.80 |
Authors | Studies |
---|---|
Sil, A | 1 |
Bhattacharjee, MS | 1 |
Chandra, A | 1 |
Pramanik, JD | 1 |
Khellaf, L | 1 |
Cosserat, J | 1 |
Calas, A | 1 |
Brasme, H | 1 |
Charles, P | 1 |
Chen, DH | 1 |
Zhou, HR | 1 |
Zhang, YG | 1 |
Shen, GY | 1 |
Xu, C | 1 |
Guan, CL | 1 |
Shimada, Y | 1 |
Suyama, Y | 1 |
Koizumi, M | 1 |
Hagiwara, K | 1 |
Soria, A | 1 |
Bernier, C | 1 |
Veyrac, G | 1 |
Barbaud, A | 1 |
Puymirat, E | 1 |
Milpied, B | 1 |
Nakamura, R | 1 |
Ozeki, T | 1 |
Hirayama, N | 1 |
Sekine, A | 2 |
Yamashita, T | 1 |
Mashimo, Y | 1 |
Mizukawa, Y | 1 |
Shiohara, T | 2 |
Watanabe, H | 1 |
Sueki, H | 1 |
Ogawa, K | 1 |
Asada, H | 1 |
Kaniwa, N | 1 |
Tsukagoshi, E | 1 |
Matsunaga, K | 1 |
Niihara, H | 1 |
Yamaguchi, Y | 1 |
Aihara, M | 1 |
Mushiroda, T | 1 |
Saito, Y | 1 |
Morita, E | 1 |
Sahm, J | 1 |
de Groot, K | 1 |
Schreiber, J | 1 |
Winward, J | 1 |
Lyckholm, L | 1 |
Brown, SM | 1 |
Mokadem, M | 1 |
Balconi, SN | 1 |
Lopes, NT | 1 |
Luzzatto, L | 1 |
Bonamigo, RR | 1 |
Arce, E | 1 |
Quera, R | 1 |
Flores, L | 1 |
Blamey, R | 1 |
Deschamps, A | 1 |
Samain, A | 1 |
Carvalho, P | 1 |
Courville, P | 1 |
Levesque, H | 1 |
Musette, P | 1 |
Joly, P | 1 |
Lang, M | 1 |
Fish, J | 1 |
Covelli, C | 1 |
Schreiber, BE | 1 |
Wu, X | 1 |
Yang, F | 1 |
Chen, S | 1 |
Xiong, H | 1 |
Zhu, Q | 1 |
Gao, X | 1 |
Xing, Q | 1 |
Luo, X | 1 |
Kenani, Z | 1 |
Lahouel, I | 1 |
Belhadjali, H | 1 |
Soua, Y | 1 |
Aouam, K | 1 |
Youssef, M | 1 |
Zili, J | 1 |
Jeimy, S | 1 |
McRae, K | 1 |
Pattani, R | 1 |
Lian, BS | 1 |
Busmanis, I | 1 |
Lee, HY | 1 |
Parkins, G | 1 |
White, B | 1 |
Hernández, N | 1 |
Borrego, L | 1 |
Soler, E | 1 |
Hernández, J | 1 |
Pirklbauer, M | 1 |
Gruber, J | 1 |
Raithatha, N | 1 |
Mehrtens, S | 1 |
Mouyis, M | 1 |
Manson, J | 1 |
Ortonne, N | 1 |
Valeyrie-Allanore, L | 1 |
Bastuji-Garin, S | 1 |
Wechsler, J | 1 |
de Feraudy, S | 1 |
Duong, TA | 1 |
Delfau-Larue, MH | 1 |
Chosidow, O | 1 |
Wolkenstein, P | 1 |
Roujeau, JC | 1 |
Chebbi, W | 1 |
Souissi, J | 1 |
Chelli, J | 1 |
Larbi, F | 1 |
Zantour, B | 1 |
Habib Sfar, M | 1 |
Fathallah, N | 1 |
Slim, R | 1 |
Rached, S | 1 |
Hachfi, W | 1 |
Letaief, A | 1 |
Ben Salem, C | 1 |
Thacker, H | 1 |
Shah, M | 1 |
Tulle, R | 1 |
Kato, M | 1 |
Kano, Y | 1 |
Sato, Y | 1 |
Sussman, S | 1 |
Devlin, V | 1 |
Dimitriades, VR | 1 |
Adwan, MH | 1 |
Saito, T | 1 |
Ito, S | 1 |
Tsunoda, Y | 1 |
Sumazaki, Y | 1 |
Tanaka, T | 1 |
Takoi, H | 1 |
Lin, SY | 1 |
Yatagai, Y | 1 |
Hayasihara, K | 1 |
1 review available for sulfasalazine and DRESS Syndrome
Article | Year |
---|---|
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Bone Density Conservatio | 2017 |
27 other studies available for sulfasalazine and DRESS Syndrome
Article | Year |
---|---|
Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) with concomitant acute chikungunya virus infection: possible role of new viral trigger.
Topics: Chikungunya Fever; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Sulfasalazine | 2021 |
Unusual neurological and cardiac complications of drug reaction with eosinophilia and systemic symptoms syndrome: a case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Drug Hyperse | 2021 |
Drug hypersensitivity syndrome induced by sulfasalazine: A case report.
Topics: Colitis, Ulcerative; Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Exanthema; Humans; Male; | 2022 |
Laryngeal edema in drug reaction with eosinophilia and systemic symptoms syndrome due to sulfasalazine.
Topics: Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Laryngeal Edema; Male; Middle Aged; | 2023 |
Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
Topics: Adult; Aged; Allopurinol; Anti-Bacterial Agents; Contrast Media; Drug Hypersensitivity Syndrome; Fem | 2020 |
Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients.
Topics: Adult; Drug Hypersensitivity Syndrome; Female; Genetic Predisposition to Disease; HLA-A11 Antigen; H | 2020 |
Sulfasalazine-induced mononucleosis-like-illness and haemolysis.
Topics: Adult; Antirheumatic Agents; Drug Hypersensitivity Syndrome; Epstein-Barr Virus Infections; Female; | 2021 |
Case of relapsing sulfasalazine-induced hypersensitivity syndrome upon re-exposure.
Topics: Drug Hypersensitivity Syndrome; Female; Humans; Middle Aged; Recurrence; Retreatment; Sulfasalazine | 2020 |
Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?
Topics: COVID-19; Drug Hypersensitivity Syndrome; Female; Humans; SARS-CoV-2; Sulfasalazine; Young Adult | 2021 |
[DRESS syndrome induced by sulfasalazine. Report of one case].
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Drug Hypersensitivity Syndrome; Eosinophilia; Female; | 2020 |
A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms.
Topics: Adult; Antirheumatic Agents; Colchicine; Drug Hypersensitivity Syndrome; Familial Mediterranean Feve | 2018 |
DRESS syndrome triple whammy: sulfasalazine, amoxicillin and HHV-7.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Arthritis, Reactive; DNA, Viral; Dose-Response Relationsh | 2017 |
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Allopurinol; Carbamazepine; China; DNA, Vir | 2018 |
Is p-phenylenediamine a marker of sulfasalazine allergy?
Topics: Adult; Anti-Infective Agents; Coloring Agents; Cross Reactions; Drug Hypersensitivity Syndrome; Huma | 2018 |
A 63-year-old returned traveller with fever, rash, hepatitis and eosinophilia.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Live | 2018 |
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Topics: Alopecia; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Dermatologic Agents; Dr | 2018 |
DRESS syndrome presenting like septic shock.
Topics: Adult; Diagnosis, Differential; Drug Eruptions; Drug Hypersensitivity Syndrome; Drug-Related Side Ef | 2013 |
Sulfasalazine-induced linear immunoglobulin A bullous dermatosis with DRESS.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Hypersensitivity Syndrome; Female; Humans; Immunoglobu | 2013 |
[DRESS syndrome following sulfasalazine treatment].
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Drug Hypersensitivity Syndrome; Female; Humans | 2014 |
Rash and fever after sulfasalazine use.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Hypersensitivity Syndrome; Exanthema; Female; F | 2014 |
Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; B-Lymphocytes; Carba | 2015 |
[DRESS syndrome: report of three cases].
Topics: Adolescent; Adult; Carbamazepine; Drug Combinations; Drug Hypersensitivity Syndrome; Female; Glucosa | 2014 |
Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.
Topics: Adult; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Hypersens | 2015 |
DRESS Syndrome: Drug Rash with Eosinophilia and Systemic Symptoms.
Topics: Antirheumatic Agents; Drug Hypersensitivity Syndrome; Female; Humans; Middle Aged; Sulfasalazine | 2015 |
Severe Agranulocytosis in Two Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2016 |
A Teenager With Sulfasalazine-Associated DRESS Syndrome After the Introduction of Amoxicillin.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Hypers | 2017 |
Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome.
Topics: Aged; Allopurinol; Antitubercular Agents; Drug Hypersensitivity Syndrome; Female; Humans; Liver Cirr | 2012 |